Science Breakfasts: A Decade of Diplomatic Engagement with U.S. Tech Leaders

For decades, the bridge between international diplomats and America’s scientific and technological elite has been strengthened by the monthly Science Breakfasts co-organized by the Office for Science and Technology of the Embassy of France in Washington, D.C., together with the SDC. Since January 2007, these gatherings have hosted 30 to 40 science counselors from 15 to 20 countries, offering a unique, off‑the‑record setting to engage with leaders from the U.S. Patent and Trademark Office, the State Department, the National Intelligence Council, the AAAS, and other pillars of the American research landscape. In 2026, with global innovation moving at breakneck speed, the value of these breakfasts is greater than ever—especially when it comes to understanding the legal and regulatory currents that can make or break international collaboration.

From Patent Law to Pandemic Preparedness: Key Themes at the French Embassy Breakfasts

The speaker roster reads like a who’s who of U.S. science policy. April 2014 brought Michelle K. Lee, then Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO, who discussed patent reform and its impact on global tech transfer. Dr. E. William Colglazier, Science and Technology Adviser to the Secretary of State, spoke in March 2014 about harnessing S&T for diplomatic objectives. Brian D. Nordmann, Director of the Office of Verification and Transparency Technologies, covered arms‑control verification—a topic that remains critical as emerging biotechnologies challenge existing treaties. More recently, sessions have tackled data analytics, federal R&D budgets, and international research partnerships. That said, the true power of these breakfasts lies in the candid, unstructured dialogue that follows each presentation, allowing embassy counselors to pose questions that touch on everything from patent litigation to adverse event reporting for medical devices brought into global supply chains.

DateSpeakerTitleRelevance in 2026
Apr. 2014Michelle K. LeeDeputy Under Secretary, USPTOPatent litigation, AI‑related IP, class action risk in tech licensing
Mar. 2014Dr. E. William ColglazierScience Adviser, U.S. State DepartmentDiplomatic frameworks for handling cross‑border adverse events
Nov. 2013Brian D. NordmannDir., Verification & Transparency TechnologiesBiosecurity and emerging tech regulation; FDA oversight of dual‑use goods
Oct. 2013Matthew HourihanDirector, R&D Budget & Policy, AAASFederal funding shifts; impact on mass tort research and compensation schemes
Jun. 2013Mathew BurrowsCounselor, National Intelligence CouncilStrategic risk assessment for tech‑driven class actions and MDLs

Legal Frameworks for Innovation: What the 2026 Diplomat Must Know

The intersection of science diplomacy and U.S. law is becoming inescapable. When a diplomat from a European embassy learns about a new FDA‑approved medical device at a Science Breakfast, they must immediately consider how that device will be regulated back home—and what happens if an adverse event occurs. In 2026, the U.S. legal system handles such disputes through a well‑established hierarchy of litigation structures. Product liability claims are frequently consolidated into a multidistrict litigation (MDL), which can handle thousands of individual plaintiffs from multiple countries. Cases involving pharmaceuticals and medical devices often evolve into a mass tort or a class action, where the statute of limitations varies by state and by the nature of the alleged harm. A diplomat who understands these mechanisms can better advise their government on whether to join a settlement or pursue independent compensation strategies. Breakfast conversations with experts like Michelle Lee provide the perfect opportunity to ask about pending litigation trends and the role of the FDA in pre‑market review.

"Together with the SDC, the Office for Science and Technology of the Embassy of France in Washington, D.C. organizes monthly Science Breakfasts, inviting a prominent member of the American science and technology community to speak to an audience of counselors from embassies in Washington."
Original Science Breakfast Page | Archive Backup

Practical Steps for Embassy Counselors Attending the Science Breakfasts

To maximize the legal and diplomatic value of these sessions, we recommend the following approach:

  • Prepare a brief on pending U.S. litigation relevant to the speaker’s domain—for example, if the talk covers AI, ensure you know the current MDL for AI‑related patent claims.
  • Ask about adverse event data sharing between U.S. agencies (FDA, NIH) and foreign governments, especially for medical technologies discussed by the speaker.
  • Note the statute of limitations for any product liability or IP disputes that may affect your country’s interests. The breakfast is a safe space to ask about enforcement timelines.
  • Document key insights about class action or mass tort trends, as these shape risk profiles for your nation’s imports and collaborative research.
  • Follow up with the host embassy’s legal attaché to discuss settlement strategies and potential plaintiff coordination.

Since 2007, these breakfasts have proven that informal dialogue can drive formal policy understanding. In 2026, with global technology tied ever more tightly to U.S. legal frameworks, attending a single breakfast could arm a diplomat with the knowledge needed to avert a cross‑border litigation crisis. If your embassy is navigating a technology‑related dispute, potential adverse event reporting, or a pending class action that may affect your country’s citizens, we urge you to understand your legal options by engaging with the experts who regularly appear at these events.

Our site continues to track these breakfasts and provide resources for diplomats. Should you need guidance on how to participate or how to apply the legal insights gained, please reach out to our advisory team. The next generation of science diplomacy demands that every counselor be as fluent in litigation trends as they are in laboratory breakthroughs.

Archive continuity: Heritage note: Reference material curated in prior years is retained for readers of science and history. While layout is occasionally updated, the documented facts of each legacy page are preserved.

Highlighted archive entries

Editorial staff occasionally refresh this list when new reference pages are published.